Sovleplenib

Sovleplenib(HMPL-523) is a highly potent and selective SYK inhibitor with IC50 of 0.025 μM, that exhibits anti-tumor activities in vitro and in vivo. Sovleplenib exhibits synergistic activities in combination with BTK, PI3Kδ, and Bcl2 family inhibitors in killing human-diffused large B cell lymphoma (DLBCL).

Price Not Available 5mg Sovleplenib Supplier Page
Trivial name HMPL-523
Catalog Number E4580
Molecular Formula C24H30N6O3S
CAS# 1415792-84-5
Inchi #N/A
Inchi Key #N/A
Size 5mg
Supplier Page http://www.selleckchem.com/products/sovleplenib-hmpl-523.html
Additional Information https://file.selleck.cn/downloads/struct/e4580-Sovleplenib-chemical-structure.png